Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom.

Burn E. et al, (2022), Nat commun, 13

Impact of the COVID-19 pandemic on eating disorders diagnoses among adolescents and young adults in Catalonia: A population-based cohort study.

Raventós B. et al, (2022), Int j eat disord

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain.

Burn E. et al, (2022), Nature communications, 13

Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.

Li X. et al, (2022), Bmj, 379

Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the Global South.

Junior EPP. et al, (2022), J am med inform assoc

Data Resource Profile: The Information System for Research in Primary Care (SIDIAP).

Recalde M. et al, (2022), Int j epidemiol

Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study.

Raventós B. et al, (2022), Bmj open, 12

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.

Burn E. et al, (2022), Pharmacoepidemiol drug saf

Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe.

Morales DR. et al, (2022), J asthma, 1 - 11

Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network.

Williams RD. et al, (2022), Bmc med res methodol, 22

Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.

Kostka K. et al, (2022), Clin epidemiol, 14, 369 - 384

Establishing and characterising large COVID-19 cohorts after mapping the Information System for Research in Primary Care in Catalonia to the OMOP Common Data Model

Burn E. et al, (2021)

Cancer and the risk of COVID-19 diagnosis, hospitalisation, and death: a population-based multi-state cohort study including 4,618,377 adults in Catalonia, Spain.

Roel E. et al, (2021), Int j cancer

“Association between COVID-19 vaccination, infection, and risk of Guillain-Barre syndrome, Bell’s palsy, encephalomyelitis and transverse myelitis: a population-based cohort and self-controlled case series analysis”

Li X. et al, (2021)

Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD

Markus AF. et al, (2021), Pharmacoepidemiology and drug safety, 30, 322 - 323

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.

Lane JCE. et al, (2021), Rheumatology (oxford), 60, 3222 - 3234

Cancer and the risk of COVID-19 diagnosis, hospitalisation, and death: a population-based multi-state cohort study including 4,618,377 adults in Catalonia, Spain

Roel E. et al, (2021)

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 20.6 million people in six European countries

Burn E. et al, (2021)

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.

Prats-Uribe A. et al, (2021), Bmj, 373

Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS.

Prieto-Alhambra D. et al, (2021)

Load More

Include forthcoming?